FENC logo

FENC
Fennec Pharmaceuticals Inc

1,321
Mkt Cap
$236.16M
Volume
125,076.00
52W High
$9.92
52W Low
$5.65
PE Ratio
-19.91
FENC Fundamentals
Price
$6.85
Prev Close
$6.84
Open
$6.82
50D MA
$7.29
Beta
0.98
Avg. Volume
227,348.07
EPS (Annual)
-$0.3409
P/B
6.60
Rev/Employee
$1.28M
$184.20
Loading...
Loading...
News
all
press releases
Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven research firms that are presently covering the stock...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below Fifty Day Moving Average - Here's What Happened
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average - What's Next...
MarketBeat·10d ago
News Placeholder
Adherex Technologies (NASDAQ:FENC) Given "Outperform" Rating at Wedbush
Wedbush reiterated an "outperform" rating and issued a $13.00 target price on shares of Adherex Technologies in a research note on Thursday...
MarketBeat·12d ago
News Placeholder
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average - What's Next?
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average - Here's What Happened...
MarketBeat·18d ago
News Placeholder
Adherex Technologies (NASDAQ:FENC) Cut to Hold at Wall Street Zen
Wall Street Zen cut shares of Adherex Technologies from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·24d ago
News Placeholder
Adherex Technologies (NASDAQ:FENC) Director Rosty Raykov Sells 10,946 Shares
Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) Director Rosty Raykov sold 10,946 shares of Adherex Technologies stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $6.31, for a total value of $69,069.26. Following the completion of the transaction...
MarketBeat·25d ago
News Placeholder
HC Wainwright Has Bearish Forecast for FENC Q1 Earnings
Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for shares of Adherex Technologies in a research note issued...
MarketBeat·27d ago
News Placeholder
Equities Analysts Offer Predictions for TSE:FRX Q1 Earnings
Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at HC Wainwright lowered their Q1 2026 earnings estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC...
MarketBeat·27d ago
News Placeholder
HC Wainwright Issues Negative Forecast for TSE:FRX Earnings
Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at HC Wainwright dropped their Q3 2026 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company...
MarketBeat·28d ago
News Placeholder
HC Wainwright Issues Negative Forecast for FENC Earnings
Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Research analysts at HC Wainwright cut their Q3 2026 EPS estimates for shares of Adherex Technologies in a note issued to investors on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings pe...
MarketBeat·28d ago
<
1
2
...
>

Latest FENC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.